1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Intracranial Atherosclerotic Disease Treatment Consumption 2016-2026

2.1.2 Intracranial Atherosclerotic Disease Treatment Consumption CAGR by Region

2.2 Intracranial Atherosclerotic Disease Treatment Segment by Type

2.2.1 Stent

2.2.2 PTA Balloon

2.3 Intracranial Atherosclerotic Disease Treatment Sales by Type

2.3.1 Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2016-2021)

2.3.2 Global Intracranial Atherosclerotic Disease Treatment Revenue and Market Share by Type (2016-2021)

2.3.3 Global Intracranial Atherosclerotic Disease Treatment Sale Price by Type (2016-2021)

2.4 Intracranial Atherosclerotic Disease Treatment Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Other

2.5 Intracranial Atherosclerotic Disease Treatment Sales by Application

2.5.1 Global Intracranial Atherosclerotic Disease Treatment Sale Market Share by Application (2016-2021)

2.5.2 Global Intracranial Atherosclerotic Disease Treatment Revenue and Market Share by Application (2016-2021)

2.5.3 Global Intracranial Atherosclerotic Disease Treatment Sale Price by Application (2016-2021)

3 Global Intracranial Atherosclerotic Disease Treatment by Company

3.1 Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Company

3.1.1 Global Intracranial Atherosclerotic Disease Treatment Sales by Company (2019-2021)

3.1.2 Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Company (2019-2021)

3.2 Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Company

3.2.1 Global Intracranial Atherosclerotic Disease Treatment Revenue by Company (2019-2021)

3.2.2 Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Company (2019-2021)

3.3 Global Intracranial Atherosclerotic Disease Treatment Sale Price by Company

3.4 Global Manufacturers Intracranial Atherosclerotic Disease Treatment Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Intracranial Atherosclerotic Disease Treatment Product Location Distribution

3.4.2 Players Intracranial Atherosclerotic Disease Treatment Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Intracranial Atherosclerotic Disease Treatment by Region

4.1 Global Intracranial Atherosclerotic Disease Treatment by Region

4.1.1 Global Intracranial Atherosclerotic Disease Treatment Sales by Region

4.1.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Region

4.2 Americas Intracranial Atherosclerotic Disease Treatment Sales Growth

4.3 APAC Intracranial Atherosclerotic Disease Treatment Sales Growth

4.4 Europe Intracranial Atherosclerotic Disease Treatment Sales Growth

4.5 Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales Growth

5 Americas

5.1 Americas Intracranial Atherosclerotic Disease Treatment Sales by Country

5.1.1 Americas Intracranial Atherosclerotic Disease Treatment Sales by Country (2016-2021)

5.1.2 Americas Intracranial Atherosclerotic Disease Treatment Revenue by Country (2016-2021)

5.2 Americas Intracranial Atherosclerotic Disease Treatment Sales by Type

5.3 Americas Intracranial Atherosclerotic Disease Treatment Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Intracranial Atherosclerotic Disease Treatment Sales by Region

6.1.1 APAC Intracranial Atherosclerotic Disease Treatment Sales by Region (2016-2021)

6.1.2 APAC Intracranial Atherosclerotic Disease Treatment Revenue by Region (2016-2021)

6.2 APAC Intracranial Atherosclerotic Disease Treatment Sales by Type

6.3 APAC Intracranial Atherosclerotic Disease Treatment Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Intracranial Atherosclerotic Disease Treatment by Country

7.1.1 Europe Intracranial Atherosclerotic Disease Treatment Sales by Country (2016-2021)

7.1.2 Europe Intracranial Atherosclerotic Disease Treatment Revenue by Country (2016-2021)

7.2 Europe Intracranial Atherosclerotic Disease Treatment Sales by Type

7.3 Europe Intracranial Atherosclerotic Disease Treatment Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Intracranial Atherosclerotic Disease Treatment by Country

8.1.1 Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales by Country (2016-2021)

8.1.2 Middle East & Africa Intracranial Atherosclerotic Disease Treatment Revenue by Country (2016-2021)

8.2 Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales by Type

8.3 Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Intracranial Atherosclerotic Disease Treatment Distributors

10.3 Intracranial Atherosclerotic Disease Treatment Customer

11 Global Intracranial Atherosclerotic Disease Treatment Market Forecast

11.1 Global Intracranial Atherosclerotic Disease Treatment Forecast by Region

11.1.1 Global Intracranial Atherosclerotic Disease Treatment Forecast by Regions (2021-2026)

11.2.2 Global Intracranial Atherosclerotic Disease Treatment Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Intracranial Atherosclerotic Disease Treatment Forecast by Type

11.7 Global Intracranial Atherosclerotic Disease Treatment Forecast by Application

12 Key Players Analysis

12.1 Stryker

12.1.1 Stryker Company Information

12.1.2 Stryker Intracranial Atherosclerotic Disease Treatment Product Offered

12.1.3 Stryker Intracranial Atherosclerotic Disease Treatment Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Stryker Main Business Overview

12.1.5 Stryker Latest Developments

12.2 Balt

12.2.1 Balt Company Information

12.2.2 Balt Intracranial Atherosclerotic Disease Treatment Product Offered

12.2.3 Balt Intracranial Atherosclerotic Disease Treatment Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Balt Main Business Overview

12.2.5 Balt Latest Developments

12.3 TERUMO

12.3.1 TERUMO Company Information

12.3.2 TERUMO Intracranial Atherosclerotic Disease Treatment Product Offered

12.3.3 TERUMO Intracranial Atherosclerotic Disease Treatment Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 TERUMO Main Business Overview

12.3.5 TERUMO Latest Developments

12.4 MicroPort

12.4.1 MicroPort Company Information

12.4.2 MicroPort Intracranial Atherosclerotic Disease Treatment Product Offered

12.4.3 MicroPort Intracranial Atherosclerotic Disease Treatment Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 MicroPort Main Business Overview

12.4.5 MicroPort Latest Developments

12.5 Acandis

12.5.1 Acandis Company Information

12.5.2 Acandis Intracranial Atherosclerotic Disease Treatment Product Offered

12.5.3 Acandis Intracranial Atherosclerotic Disease Treatment Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Acandis Main Business Overview

12.5.5 Acandis Latest Developments

...

13 Research Findings and Conclusion

List of Tables

Table 1. Intracranial Atherosclerotic Disease Treatment Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Stent

Table 3. Major Players of PTA Balloon

Table 4. Global Intracranial Atherosclerotic Disease Treatment Sales by Type (2016-2021) & (K Units)

Table 5. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2016-2021)

Table 6. Global Intracranial Atherosclerotic Disease Treatment Revenue by Type (2016-2021) & ($ million)

Table 7. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2016-2021)

Table 8. Global Intracranial Atherosclerotic Disease Treatment Sale Price by Type (2016-2021)

Table 9. Global Intracranial Atherosclerotic Disease Treatment Sales by Application (2016-2021) & (K Units)

Table 10. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2016-2021)

Table 11. Global Intracranial Atherosclerotic Disease Treatment Value by Application (2016-2021)

Table 12. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2016-2021)

Table 13. Global Intracranial Atherosclerotic Disease Treatment Sale Price by Application (2016-2021)

Table 14. Global Intracranial Atherosclerotic Disease Treatment Sales by Company (2019-2021) & (K Units)

Table 15. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Company (2019-2021)

Table 16. Global Intracranial Atherosclerotic Disease Treatment Revenue by Company (2019-2021) ($ Millions)

Table 17. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Company (2019-2021)

Table 18. Global Intracranial Atherosclerotic Disease Treatment Sale Price by Company (2019-2021)

Table 19. Key Manufacturers Intracranial Atherosclerotic Disease Treatment Producing Area Distribution and Sales Area

Table 20. Players Intracranial Atherosclerotic Disease Treatment Products Offered

Table 21. Intracranial Atherosclerotic Disease Treatment Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Intracranial Atherosclerotic Disease Treatment Sales by Region (2016-2021) (K Units)

Table 25. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region (2016-2021)

Table 26. Global Intracranial Atherosclerotic Disease Treatment Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region (2016-2021)

Table 28. Americas Intracranial Atherosclerotic Disease Treatment Sales by Country (2016-2021) & (K Units)

Table 29. Americas Intracranial Atherosclerotic Disease Treatment Sales Market Share by Country (2016-2021)

Table 30. Americas Intracranial Atherosclerotic Disease Treatment Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Country (2016-2021)

Table 32. Americas Intracranial Atherosclerotic Disease Treatment Sales by Type (2016-2021) & (K Units)

Table 33. Americas Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2016-2021)

Table 34. Americas Intracranial Atherosclerotic Disease Treatment Sales by Application (2016-2021) & (K Units)

Table 35. Americas Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2016-2021)

Table 36. APAC Intracranial Atherosclerotic Disease Treatment Sales by Region (2016-2021) & (K Units)

Table 37. APAC Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region (2016-2021)

Table 38. APAC Intracranial Atherosclerotic Disease Treatment Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region (2016-2021)

Table 40. APAC Intracranial Atherosclerotic Disease Treatment Sales by Type (2016-2021) & (K Units)

Table 41. APAC Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2016-2021)

Table 42. APAC Intracranial Atherosclerotic Disease Treatment Sales by Application (2016-2021) & (K Units)

Table 43. APAC Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2016-2021)

Table 44. Europe Intracranial Atherosclerotic Disease Treatment Sales by Country (2016-2021) & (K Units)

Table 45. Europe Intracranial Atherosclerotic Disease Treatment Sales Market Share by Country (2016-2021)

Table 46. Europe Intracranial Atherosclerotic Disease Treatment Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Country (2016-2021)

Table 48. Europe Intracranial Atherosclerotic Disease Treatment Sales by Type (2016-2021) & (K Units)

Table 49. Europe Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2016-2021)

Table 50. Europe Intracranial Atherosclerotic Disease Treatment Sales by Application (2016-2021) & (K Units)

Table 51. Europe Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales by Country (2016-2021) & (K Units)

Table 53. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales by Type (2016-2021) & (K Units)

Table 57. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales by Application (2016-2021) & (K Units)

Table 59. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2016-2021)

Table 60. Key and Potential Regions of Intracranial Atherosclerotic Disease Treatment

Table 61. Key Application and Potential Industries of Intracranial Atherosclerotic Disease Treatment

Table 62. Key Challenges of Intracranial Atherosclerotic Disease Treatment

Table 63. Key Trends of Intracranial Atherosclerotic Disease Treatment

Table 64. Intracranial Atherosclerotic Disease Treatment Distributors List

Table 65. Intracranial Atherosclerotic Disease Treatment Customer List

Table 66. Global Intracranial Atherosclerotic Disease Treatment Sales Forecast by Region (2021-2026) & (K Units)

Table 67. Global Intracranial Atherosclerotic Disease Treatment Consumption Market Forecast by Region

Table 68. Global Intracranial Atherosclerotic Disease Treatment Revenue Forecast by Region (2021-2026) & ($ millions)

Table 69. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share Forecast by Region (2021-2026)

Table 70. Americas Intracranial Atherosclerotic Disease Treatment Sales Forecast by Country (2021-2026) & (K Units)

Table 71. Americas Intracranial Atherosclerotic Disease Treatment Revenue Forecast by Country (2021-2026) & ($ millions)

Table 72. APAC Intracranial Atherosclerotic Disease Treatment Sales Forecast by Region (2021-2026) & (K Units)

Table 73. APAC Intracranial Atherosclerotic Disease Treatment Revenue Forecast by Region (2021-2026) & ($ millions)

Table 74. Europe Intracranial Atherosclerotic Disease Treatment Sales Forecast by Country (2021-2026) & (K Units)

Table 75. Europe Intracranial Atherosclerotic Disease Treatment Revenue Forecast by Country (2021-2026) & ($ millions)

Table 76. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales Forecast by Country (2021-2026) & (K Units)

Table 77. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Global Intracranial Atherosclerotic Disease Treatment Sales Forecast by Type (2021-2026) & (K Units)

Table 79. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share Forecast by Type (2021-2026)

Table 80. Global Intracranial Atherosclerotic Disease Treatment Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 81. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share Forecast by Type (2021-2026)

Table 82. Global Intracranial Atherosclerotic Disease Treatment Sales Forecast by Application (2021-2026) & (K Units)

Table 83. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share Forecast by Application (2021-2026)

Table 84. Global Intracranial Atherosclerotic Disease Treatment Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 85. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share Forecast by Application (2021-2026)

Table 86. Stryker Basic Information, Intracranial Atherosclerotic Disease Treatment Manufacturing Base, Sales Area and Its Competitors

Table 87. Stryker Intracranial Atherosclerotic Disease Treatment Product Offered

Table 88. Stryker Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 89. Stryker Main Business

Table 90. Stryker Latest Developments

Table 91. Balt Basic Information, Intracranial Atherosclerotic Disease Treatment Manufacturing Base, Sales Area and Its Competitors

Table 92. Balt Intracranial Atherosclerotic Disease Treatment Product Offered

Table 93. Balt Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 94. Balt Main Business

Table 95. Balt Latest Developments

Table 96. TERUMO Basic Information, Intracranial Atherosclerotic Disease Treatment Manufacturing Base, Sales Area and Its Competitors

Table 97. TERUMO Intracranial Atherosclerotic Disease Treatment Product Offered

Table 98. TERUMO Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 99. TERUMO Main Business

Table 100. TERUMO Latest Developments

Table 101. MicroPort Basic Information, Intracranial Atherosclerotic Disease Treatment Manufacturing Base, Sales Area and Its Competitors

Table 102. MicroPort Intracranial Atherosclerotic Disease Treatment Product Offered

Table 103. MicroPort Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 104. MicroPort Main Business

Table 105. MicroPort Latest Developments

Table 106. Acandis Basic Information, Intracranial Atherosclerotic Disease Treatment Manufacturing Base, Sales Area and Its Competitors

Table 107. Acandis Intracranial Atherosclerotic Disease Treatment Product Offered

Table 108. Acandis Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 109. Acandis Main Business

Table 110. Acandis Latest Developments

List of Figures

Figure 1. Picture of Intracranial Atherosclerotic Disease Treatment

Figure 2. Intracranial Atherosclerotic Disease Treatment Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Intracranial Atherosclerotic Disease Treatment Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Intracranial Atherosclerotic Disease Treatment Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Intracranial Atherosclerotic Disease Treatment Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Stent

Figure 10. Product Picture of PTA Balloon

Figure 11. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type in 2020

Figure 12. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2016-2021)

Figure 13. Intracranial Atherosclerotic Disease Treatment Consumed in Hospital

Figure 14. Global Intracranial Atherosclerotic Disease Treatment Market: Hospital (2016-2021) & (K Units)

Figure 15. Intracranial Atherosclerotic Disease Treatment Consumed in Clinic

Figure 16. Global Intracranial Atherosclerotic Disease Treatment Market: Clinic (2016-2021) & (K Units)

Figure 17. Intracranial Atherosclerotic Disease Treatment Consumed in Other

Figure 18. Global Intracranial Atherosclerotic Disease Treatment Market: Other (2016-2021) & (K Units)

Figure 19. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2016-2021)

Figure 20. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application in 2020

Figure 21. Intracranial Atherosclerotic Disease Treatment Revenue Market by Company in 2020 ($ Million)

Figure 22. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Company in 2020

Figure 23. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Regions (2016-2021)

Figure 24. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region in 2020

Figure 25. Americas Intracranial Atherosclerotic Disease Treatment Sales 2016-2021 (K Units)

Figure 26. Americas Intracranial Atherosclerotic Disease Treatment Revenue 2016-2021 ($ Millions)

Figure 27. APAC Intracranial Atherosclerotic Disease Treatment Sales 2016-2021 (K Units)

Figure 28. APAC Intracranial Atherosclerotic Disease Treatment Revenue 2016-2021 ($ Millions)

Figure 29. Europe Intracranial Atherosclerotic Disease Treatment Sales 2016-2021 (K Units)

Figure 30. Europe Intracranial Atherosclerotic Disease Treatment Revenue 2016-2021 ($ Millions)

Figure 31. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales 2016-2021 (K Units)

Figure 32. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Revenue 2016-2021 ($ Millions)

Figure 33. Americas Intracranial Atherosclerotic Disease Treatment Sales Market Share by Country in 2020

Figure 34. Americas Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Country in 2020

Figure 35. Americas Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type in 2020

Figure 36. Americas Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application in 2020

Figure 37. United States Intracranial Atherosclerotic Disease Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 38. Canada Intracranial Atherosclerotic Disease Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 39. Mexico Intracranial Atherosclerotic Disease Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 40. Brazil Intracranial Atherosclerotic Disease Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 41. APAC Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region in 2020

Figure 42. APAC Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Regions in 2020

Figure 43. APAC Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type in 2020

Figure 44. APAC Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application in 2020

Figure 45. China Intracranial Atherosclerotic Disease Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 46. Japan Intracranial Atherosclerotic Disease Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 47. Korea Intracranial Atherosclerotic Disease Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 48. Southeast Asia Intracranial Atherosclerotic Disease Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 49. India Intracranial Atherosclerotic Disease Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 50. Australia Intracranial Atherosclerotic Disease Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 51. Europe Intracranial Atherosclerotic Disease Treatment Sales Market Share by Country in 2020

Figure 52. Europe Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Country in 2020

Figure 53. Europe Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type in 2020

Figure 54. Europe Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application in 2020

Figure 55. Germany Intracranial Atherosclerotic Disease Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 56. France Intracranial Atherosclerotic Disease Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 57. UK Intracranial Atherosclerotic Disease Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 58. Italy Intracranial Atherosclerotic Disease Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 59. Russia Intracranial Atherosclerotic Disease Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 60. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales Market Share by Country in 2020

Figure 61. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Country in 2020

Figure 62. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type in 2020

Figure 63. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application in 2020

Figure 64. Egypt Intracranial Atherosclerotic Disease Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 65. South Africa Intracranial Atherosclerotic Disease Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 66. Israel Intracranial Atherosclerotic Disease Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 67. Turkey Intracranial Atherosclerotic Disease Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 68. GCC Country Intracranial Atherosclerotic Disease Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles